User profiles for J. E. Zuckerman
JE zuckermanAsst Professor , Obstetrics, Gynecology and Reproductive Biology Harvard Medical School Verified email at harvard.edu Cited by 1053 |
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Therapeutics that are designed to engage RNA interference (RNAi) pathways have the
potential to provide new, major ways of imparting therapy to patients 1 , 2 . Long, double-…
potential to provide new, major ways of imparting therapy to patients 1 , 2 . Long, double-…
Targeting kidney mesangium by nanoparticles of defined size
CHJ Choi, JE Zuckerman… - Proceedings of the …, 2011 - National Acad Sciences
Nanoparticles are being investigated for numerous medical applications and are showing
potential as an emerging class of carriers for drug delivery. Investigations on how the …
potential as an emerging class of carriers for drug delivery. Investigations on how the …
Virtual histological staining of unlabelled tissue-autofluorescence images via deep learning
The histological analysis of tissue samples, widely used for disease diagnosis, involves
lengthy and laborious tissue preparation. Here, we show that a convolutional neural network …
lengthy and laborious tissue preparation. Here, we show that a convolutional neural network …
Clinical experiences with systemically administered siRNA-based therapeutics in cancer
JE Zuckerman, ME Davis - Nature reviews Drug discovery, 2015 - nature.com
Small interfering RNA (siRNA)-based therapies are emerging as a promising new anticancer
approach, and a small number of Phase I clinical trials involving patients with solid tumours …
approach, and a small number of Phase I clinical trials involving patients with solid tumours …
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
JE Zuckerman, CHJ Choi, H Han… - Proceedings of the …, 2012 - National Acad Sciences
Despite being engineered to avoid renal clearance, many cationic polymer (polycation)-based
siRNA nanoparticles that are used for systemic delivery are rapidly eliminated from the …
siRNA nanoparticles that are used for systemic delivery are rapidly eliminated from the …
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
JE Zuckerman, I Gritli, A Tolcher… - Proceedings of the …, 2014 - National Acad Sciences
Nanoparticle-based experimental therapeutics are currently being investigated in numerous
human clinical trials. CALAA-01 is a targeted, polymer-based nanoparticle containing small …
human clinical trials. CALAA-01 is a targeted, polymer-based nanoparticle containing small …
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
ST Crooke, MJ Graham, JE Zuckerman, D Brooks… - … of Pharmacology and …, 1996 - ASPET
Biophysical and pharmacokinetic properties of five analogs of ISIS 3082, a 20-mer
phosphorothioate oligodeoxynucleotide that inhibits the expression of mouse intercellular adhesion …
phosphorothioate oligodeoxynucleotide that inhibits the expression of mouse intercellular adhesion …
[HTML][HTML] Deep learning-based transformation of H&E stained tissues into special stains
Pathology is practiced by visual inspection of histochemically stained tissue slides. While
the hematoxylin and eosin (H&E) stain is most commonly used, special stains can provide …
the hematoxylin and eosin (H&E) stain is most commonly used, special stains can provide …
Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria
…, S Rehman, F Khoury, JE Zuckerman… - American Journal of …, 2021 - Elsevier
Rationale & Objective Kidney biopsy data inform us about pathologic processes associated
with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …
with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …
The human sex ratio from conception to birth
…, T Scholl, D Steinsaltz, JE Zuckerman - Proceedings of the …, 2015 - National Acad Sciences
We describe the trajectory of the human sex ratio from conception to birth by analyzing data
from (i) 3- to 6-d-old embryos, (ii) induced abortions, (iii) chorionic villus sampling, (iv) …
from (i) 3- to 6-d-old embryos, (ii) induced abortions, (iii) chorionic villus sampling, (iv) …